282 related articles for article (PubMed ID: 30820632)
1. Functional characterization of the cannabinoid receptors 1 and 2 in zebrafish larvae using behavioral analysis.
Luchtenburg FJ; Schaaf MJM; Richardson MK
Psychopharmacology (Berl); 2019 Jul; 236(7):2049-2058. PubMed ID: 30820632
[TBL] [Abstract][Full Text] [Related]
2. A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro.
Veeraraghavan P; Dekanic A; Nistri A
Neuroscience; 2016 Oct; 333():214-28. PubMed ID: 27450568
[TBL] [Abstract][Full Text] [Related]
3. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists.
Veeraraghavan P; Nistri A
Neuroscience; 2015 Sep; 303():16-33. PubMed ID: 26126926
[TBL] [Abstract][Full Text] [Related]
6. Endogenous cannabinoids induce fever through the activation of CB1 receptors.
Fraga D; Zanoni CI; Rae GA; Parada CA; Souza GE
Br J Pharmacol; 2009 Aug; 157(8):1494-501. PubMed ID: 19681872
[TBL] [Abstract][Full Text] [Related]
7. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
Pertwee RG
Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
Baldassano S; Serio R; Mule' F
Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
[TBL] [Abstract][Full Text] [Related]
9. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
10. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
11. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
12. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
Chiba T; Ueno S; Obara Y; Nakahata N
J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
[TBL] [Abstract][Full Text] [Related]
13. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy.
Medeiros P; de Freitas RL; Silva MO; Coimbra NC; Melo-Thomas L
Neuroscience; 2016 Nov; 337():17-26. PubMed ID: 27595886
[TBL] [Abstract][Full Text] [Related]
14. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
Darmani NA
J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094
[TBL] [Abstract][Full Text] [Related]
15. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms.
De Oliveira Alvares L; Genro BP; Diehl F; Quillfeldt JA
Neurobiol Learn Mem; 2008 Jul; 90(1):1-9. PubMed ID: 18342551
[TBL] [Abstract][Full Text] [Related]
16. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of allergic contact dermatitis through the endocannabinoid system.
Karsak M; Gaffal E; Date R; Wang-Eckhardt L; Rehnelt J; Petrosino S; Starowicz K; Steuder R; Schlicker E; Cravatt B; Mechoulam R; Buettner R; Werner S; Di Marzo V; Tüting T; Zimmer A
Science; 2007 Jun; 316(5830):1494-7. PubMed ID: 17556587
[TBL] [Abstract][Full Text] [Related]
19. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells.
Kishimoto S; Kobayashi Y; Oka S; Gokoh M; Waku K; Sugiura T
J Biochem; 2004 Apr; 135(4):517-24. PubMed ID: 15115777
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice.
Aliczki M; Varga ZK; Balogh Z; Haller J
Psychopharmacology (Berl); 2015 Jun; 232(12):2157-67. PubMed ID: 25547462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
